Q3 2025 · 13F-HR/A
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2026-03-18 · accession 0000904454-26-000190
$503.9M
Reported value
20
Positions
2025-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $162.7M | 32.3% | 2,449,183 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $106.2M | 21.1% | 5,623,816 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $54.7M | 10.8% | 6,641,064 | Common | SHARED |
| 75383L102 | RAPP | Rapport Therapeutics, Inc. | $53.0M | 10.5% | 1,784,517 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $33.1M | 6.57% | 4,103,430 | Common | SHARED |
| 52490G102 | LEGN | Legend Biotech Corporation | $26.6M | 5.27% | 814,586 | Common | SHARED |
| 21217B100 | CTNM | Contineum Therapeutics Inc. | $23.3M | 4.61% | 1,979,173 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $12.8M | 2.54% | 357,939 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $8.8M | 1.74% | 748,062 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $8.5M | 1.69% | 247,598 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $4.3M | 0.84% | 3,379,064 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $3.4M | 0.67% | 1,849,445 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $2.6M | 0.52% | 53,732 | Common | SHARED |
| 75120L100 | — | Rallybio Corporation | $1.8M | 0.36% | 3,636,363 | Common | SHARED |
| 55083R203 | LYEL | Lyell Immunopharma Inc. | $891,365 | 0.18% | 54,887 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $587,752 | 0.12% | 158,852 | Common | SHARED |
| 34385P108 | LAB | Standard BioTools Inc | $405,557 | 0.08% | 311,967 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $295,295 | 0.06% | 364,472 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $50,855 | 0.01% | 96,866 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $23,804 | 0.00% | 54,621 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.